Eledon reports inducement grants under nasdaq listing rule 5635(c)(4)

Irvine, calif., dec. 04, 2023 (globe newswire) -- eledon pharmaceuticals, inc. (“eledon”) (nasdaq: eldn) today announced that on december 1, 2023, the company's compensation committee granted our new chief medical officer, eliezer katz, m.d.

ELDN Ratings Summary

ELDN Quant Ranking